Clarity Diagnostics

Clarity Diagnostics is committed to providing you with top-of-the-line Diagnostic Products along with great customer service. Our goal is to make tests that are simple and effective at diagnosing problems earlier so you can provide better care to your clients. After all, better patient outcomes leads to greater patient satisfaction

Abbott Rapid Diagnostics

Abbott Rapid Diagnostics’ ID NOW is a rapid, instrument-based isothermal system for the qualitative detection of infectious diseases. Our unique IC NOW isothermal nucleic acid amplification technology provides molecular results in just minutes, allowing you to make effective clinical decisions sooner.

Visby Medical

The first commercial application of the Visby Medical single-use, rapid PCR platform received FDA EUA in 2020 for COVID-19 testing. Currently under review with the FDA is a multiplex assay for Chlamydia, Gonorrhea, and Trichomonas from a single sample, at the point of care.


The LumiraDx Platform is a next generation point of care diagnostic system that integrates techniques used in laboratory analyzers to provide lab-comparable performance on a single point of care instrument, allowing for a continued development of a broad test menu across conditions commonly diagnosed and managed in community based healthcare settings.


Cepheid is a leading molecular diagnostics company with a broad menu of tests for organisms and genetic-based diseases. With Cepheid’s GeneXpert® Xpress System and CLIA waived PCR test menu for respiratory infections and women’s and sexual health panels, Urgent Care clinics can provide on-demand, accurate, and actionable test results at the point of care. ForRead More

Jant Pharmacal Corp

Jant Pharmacal, established in 1986, offers a wide range of CLIA-waived tests for Urgent Care practices. FDA EUA CLIA-waived Covid-19 antigen tests are available in both Flu A&B/Covid-19 and single Covid-19 formats. Other tests include PT/INR, cardiac enzymes, pregnancy, mononucleosis, H. pylori, Hepatitis C, HIV, urinalysis, iFOBT, DOA and UTI.

RPS Diagnostics

RPS Diagnostics, Inc. manufactures and markets rapid, easy to use, point-of-care diagnostic tests including AdenoPlus®. AdenoPlus® is the first and only point-of-care, CLIA-waived, test for the detection of Adenoviral conjunctivitis with results in 10 minutes. For more information, please visit our website at

BD Diagnostic Systems

With more than two decades of extensive research and production experience, BD Diagnostic Systems has exhibited strong leadership in rapid detection of a wide range of pathogens including RSV and influenza virus, C. difficile, and Group A Strep. When it comes to serology testing, BD latex agglutination tests and RPR card tests have come toRead More